Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) to ...
Vanda Pharma submits BLA to US FDA for imsidolimab to treat generalized pustular psoriasis: Washington Tuesday, December 16, 2025, 15:00 Hrs [IST] Vanda Pharmaceuticals Inc., (Van ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) ...
Vanda Pharmaceuticals shares rose after the company said it had submitted a biologics license application to the Food and Drug Administration for its generalized pustular psoriasis treatment. The ...
Investing.com -- Vanda Pharmaceuticals Inc (NASDAQ:VNDA) stock jumped 5.1% Monday after the company announced it submitted a Biologics License Application (BLA) to the FDA for imsidolimab, a treatment ...
PsO is a systemic inflammatory disease that presents not only as scaly skin lesions, erythema, and itching but also affects ...
Sportschosun on MSN
Changes in skin, hair, and nails during anticancer. How to deal with it and when to recover?
The most common concern of chemotherapy patients is that their skin is not the same as before", "A handful of hair is falling out."It's hard to walk because my nails hurt" It's a story of the same ...
With the other premium services, you can dive deep into additional metrics, portfolios, commentary and information about ...
Sep. 15, 2025 Dry eyes are far more common than previously believed, with over half of adults in the US and Europe experiencing symptoms, yet most remain undiagnosed for years. The large-scale NESTS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback